Ian Clements - Net Worth and Insider Trading

Ian Clements Net Worth

The estimated net worth of Ian Clements is at least $459,570 dollars as of 2024-05-12. Ian Clements is the CFO of Mirum Pharmaceuticals Inc and owns about 18,561 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $459,570. Details can be seen in Ian Clements's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ian Clements has not made any transactions after 2021-11-26 and currently still holds the listed stock(s).

Transaction Summary of Ian Clements

To

Ian Clements Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ian Clements owns 1 companies in total, including Mirum Pharmaceuticals Inc (MIRM) .

Click here to see the complete history of Ian Clements’s form 4 insider trades.

Insider Ownership Summary of Ian Clements

Ticker Comapny Transaction Date Type of Owner
MIRM Mirum Pharmaceuticals Inc 2021-11-26 SVP Finance & Communications

Ian Clements Latest Holdings Summary

Ian Clements currently owns a total of 1 stock. Ian Clements owns 18,561 shares of Mirum Pharmaceuticals Inc (MIRM) as of November 26, 2021, with a value of $459,570.

Latest Holdings of Ian Clements

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MIRM Mirum Pharmaceuticals Inc 2021-11-26 18,561 24.76 459,570

Holding Weightings of Ian Clements


Ian Clements Form 4 Trading Tracker

According to the SEC Form 4 filings, Ian Clements has made a total of 5 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 4 buys and 1 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 1,450 shares on November 26, 2021, which cost Ian Clements around $20,503.

Insider Trading History of Ian Clements

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ian Clements Trading Performance

GuruFocus tracks the stock performance after each of Ian Clements's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ian Clements is 13.22%. GuruFocus also compares Ian Clements's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ian Clements within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ian Clements's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ian Clements

Average Return

Average return per transaction

Outperforming Transactions

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.11
Relative Return to S&P 500(%) 2.57

Ian Clements Ownership Network

Ownership Network List of Ian Clements

No Data

Ownership Network Relation of Ian Clements


Ian Clements Owned Company Details

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Ian Clements is the SVP Finance & Communications of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include Chief Financial Officer Eric Bjerkholt , Chief Operating Officer Peter Radovich , and SVP & Global Controller Jolanda Howe .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Ian Clements made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,305 shares made by Peter Radovich , a net sale of 8,137 shares made by Jolanda Howe , and a net purchase of 161,963 shares made by Patrick J Heron .

In summary, during the past 3 months, insiders sold 4,303 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 4,000 shares, with a net sale of 303 shares. During the past 18 months, 393,444 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 175,963 shares were bought by its insiders, resulting in a net sale of 217,481 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

Ian Clements Mailing Address

Above is the net worth, insider trading, and ownership report for Ian Clements. You might contact Ian Clements via mailing address: C/o Mirum Pharmaceuticals, Inc., 950 Tower Lane, Suite 1050, Foster City Ca 94404.

Discussions on Ian Clements

No discussions yet.